Kolbeck Roland Wilhelm bought ACRS
August 1, 2025 · Form 4 insider transaction
Kolbeck Roland Wilhelm bought 145,500 shares of Aclaris Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
145,500
Price
$0.00
Total value
N/A
InsiderKolbeck Roland Wilhelm
RoleOfficer
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateAugust 1, 2025
Filing dateAugust 5, 2025
Shares owned after145,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.; The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of August 1, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.